Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: -0.025 (-0.57%)
Spread: 0.25 (5.882%)
Open: 4.625
High: 4.625
Low: 4.25
Prev. Close: 4.40
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

Fri, 30th Apr 2021 10:40

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Futura Medical PLC, up 31% at 58.92 pence, 12-month range 11.1p-84p. The pharmaceutical company receives its MDR EU Quality Management Certificate for MED3000, a treatment for erectile dysfunction. "The CE mark approval of MED3000 from the EU Notified Body paves the way for approval in many countries around the world, including in the Middle East, Africa, the Far East and Latin American regions which allow 'fast-track' review based on recognition of the EU CE mark," company notes.

----------

Genedrive PLC, up 24% 90.00p, 12-month range 38.33p-302.6p. The molecular diagnostics firm says the Genedrive 96 SARS-CoV-2 Kit has been formally approved by the Indian Council of Medical Research. Kit achieves 100% sensitivity and 100% specificity in the performance evaluation conducted by the ICMR. "The company will now commence commercial activities in India through its existing distributor Divoc Health and will also be seeking additional routes to the market," it says.

----------

AIM - LOSERS

----------

Hurricane Energy PLC, down 52% at 1.1p, 12-month range 1p-12.7p. The UK-based oil & gas company enters into a lock-up agreement with an ad hoc group of bondholders supporting a transaction that will "materially deleverage" company's balance sheet, enhance liquidity position and extend its debt maturity profile. Company will execute a debt for equity conversion and a revised business strategy. "This has been a difficult period for Hurricane and its stakeholders. Following the significant downgrade to Lancaster Field reserves and future production profiles, coupled with oil price volatility, current financial projections show we will not be in a position to repay our convertible bonds at maturity from Lancaster Field cash flows," says Chief Executive Antony Maris, adding: "We acknowledge that this proposed course of action entails significant dilution for our existing shareholders, but it marks an important and necessary step in the company's efforts to secure a viable capital structure."

----------

FireAngel Safety Technology Group PLC, down 12% at 19.7p, 12-month range 10p-30p. The home safety products maker plans open offer of shares to raise up to GBP6.9 million on basis of 10 open offer share for every 33 existing ones at an issue price of 18p, with this price representing discount of 20% to Thursday's closing price of 22.4p. In separate release, reports fall in 2020 revenue to GBP39.9 million from GBP45.5 million in 2019, but pretax loss narrows to GBP9.3 million from GBP11.0 million. "There is now a clearer path out of the Covid-19 related restrictions, and while some uncertainty remains, the board is targeting improved performance and sales growth in 2021 versus 2020," FireAngel says.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Jan 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Dec 2019 10:10

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Read more
3 Dec 2019 09:39

Genedrive upbeat on latest results from RNR1 kit testing

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.

Read more
18 Nov 2019 16:00

Genedrive infant hearing loss test gets CE mark

(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.

Read more
18 Nov 2019 11:15

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Read more
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.